SCHEMBL17573111

SCHEMBL17573111

C=NC(=O)c1ccc2cc(Br)ccc2c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 2/20 0.43
CES1 P23141 2/20 0.43
DHODH Q02127 2/20 0.43
CYP2A6 P11509 1/20 0.42
SIRT1 Q96EB6 2/20 0.42
LMNA P02545 2/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
NCEH1 Q6PIU2 1/20 0.40
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
KDM4E B2RXH2 1/20 0.39
ALDH1A1 P00352 1/20 0.39
MAPT P10636 1/20 0.39
CYP3A4 P08684 2/20 0.38
KDM2B Q8NHM5 2/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP2C19 P33261 1/20 0.37
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16309346 0.81 CES2 (0.67) CES2CES1SMN1; SMN2MEN1KMT2A
SCHEMBL27709607 0.79 SLC9A1 (0.59) LMNASMN1; SMN2
SCHEMBL203205 0.76 DHODH (0.55) CES2CES1DHODHCYP2A6NCEH1
SCHEMBL30020656 0.76 DHODH (0.55) CES2CES1DHODHCYP2A6NCEH1
SCHEMBL264367 0.75 CYP2A6 (0.55) CES2CES1DHODHCYP2A6LMNA
SCHEMBL30350490 0.75 CYP2A6 (0.55) CES2CES1DHODHCYP2A6LMNA
Hydrochloric Acid SCHEMBL1001004 0.75 DHODH (0.54) DHODHCYP2A6NCEH1MEN1KMT2A
SCHEMBL613558 0.75 LCK (0.62) CES2CES1DHODHCYP2A6LMNA
SCHEMBL203740 0.75 CYP2A6 (0.46) CES2CES1DHODHCYP2A6SIRT1
Potassium Ion SCHEMBL31096456 0.73 CA1 (0.59) CES2CES1DHODHCYP2A6SIRT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2993169-A1 ARYL-PYRIDINE DERIVATIVES AS ALDOSTERONE SYNTHASE INHIBITORS Novartis AG (CH) 2016-03-09 EP disclosed